ClinicalTrials.Veeva

Menu

Bioavailability Study of K0706 in Healthy Subjects

Sun Pharma Advanced Research (SPARC) logo

Sun Pharma Advanced Research (SPARC)

Status and phase

Completed
Phase 1

Conditions

Healthy

Treatments

Drug: K0706

Study type

Interventional

Funder types

Industry

Identifiers

NCT03316820
CLR_17_07

Details and patient eligibility

About

This is single-center, single-dose, randomized, open-label, four-period, four sequence crossover study to evaluate the relative bioavailability of K0706 24 mg tablet formulation relative to 24 mg capsule formulation under fasted conditions and to evaluate the food-effect for tablet formulation in healthy subjects.

Enrollment

24 patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Willingness to provide written, informed consent for participation in the study in the compliance with the protocol requirements
  2. Adult males or females aged between 18 and 55 years
  3. Medically healthy on the basis of medical history and physical examination
  4. Woman of childbearing potential must practice an acceptable method of birth control

Exclusion criteria

  1. History of any major surgical or medical conditions within 4 weeks prior to dosing
  2. History of blood transfusion and / or plasmapheresis within 4 weeks prior to dosing
  3. Inability to swallow oral medication and / or difficulty to find peripheral access to veins or inability to undergo venipuncture
  4. Any malignancy within the past 3 years (except for non-melanoma skin cancer or cervical cancer in situ)

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

24 participants in 4 patient groups

Treatment A
Experimental group
Description:
K0706 tablet
Treatment:
Drug: K0706
Drug: K0706
Treatment B
Experimental group
Description:
K0706 tablet
Treatment:
Drug: K0706
Drug: K0706
Treatment C
Experimental group
Description:
K0706 tablet
Treatment:
Drug: K0706
Drug: K0706
Treatment D
Experimental group
Description:
K0706 capsule
Treatment:
Drug: K0706
Drug: K0706

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems